PT - JOURNAL ARTICLE AU - Hirai, Sakyo AU - Hanazawa, Ryoichi AU - Yoshimura, Masataka AU - Shigeta, Keigo AU - Sato, Yohei AU - Taira, Naoki AU - Kawano, Yoshihisa AU - Karakama, Jun AU - Obata, Yoshiki AU - Hara, Mutsuya AU - Yamada, Kenji AU - Ishii, Yosuke AU - Sawada, Kana AU - Imae, Shogo AU - Wakabayashi, Hikaru AU - Sagawa, Hirotaka AU - Fujita, Kyohei AU - Fujii, Shoko AU - Takahashi, Satoru AU - Hirakawa, Akihiro AU - Nemoto, Shigeru AU - Sumita, Kazutaka TI - Safety and efficacy of management for intraprocedural rupture during endovascular treatment for intracranial aneurysms AID - 10.1101/2024.01.23.24301699 DP - 2024 Jan 01 TA - medRxiv PG - 2024.01.23.24301699 4099 - http://medrxiv.org/content/early/2024/01/25/2024.01.23.24301699.short 4100 - http://medrxiv.org/content/early/2024/01/25/2024.01.23.24301699.full AB - Background Although intraprocedural rupture (IPR) is rare, it is a devastating complication of endovascular treatment (EVT) for intracranial aneurysms. Very few studies have been conducted on IPR, and the safety and efficacy of management techniques of IPR have not been investigated.Methods Patients who underwent IPR during EVT between 2013 and 2022 were enrolled from the multicenter observational registry. Focusing on the management of IPR, we examined its safety and efficacy using imaging markers, including increased hemorrhage and ischemic lesions evaluated using postoperative computed tomography and diffusion-weighted imaging, respectively.Results Of the 3269 EVT for intracranial aneurysms, 74 patients who underwent IPR (2.26%) were analyzed. Fifty-five patients (3.36%) experienced IPR in 1636 EVT cases for ruptured aneurysms. The multivariate analysis revealed that increased hemorrhage was significantly associated with poor outcomes (odds ratio [OR], 6.67 [95% confidence interval (CI), 1.07–41.44], p=0.042), whereas ischemic lesions were not. Regarding management techniques of IPR, antihypertensive medication use was significantly associated with increased hemorrhage (OR, 13.17 [95% CI, 2.26–76.69], p=0.004). Heparin reversal was an independent factor for ischemic lesions (OR, 4.81 [95% CI, 1.09–21.14], p=0.038).Conclusions Even though the setting of IPR may be miscellaneous, and optimal management varies depending on individual cases, heparin reversal might be associated with ischemic complications rather than being useful for controlling bleeding in IPR during EVT for ruptured aneurysms.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors did not receive a specific grant for this research from any funding agency in the public, commercial, or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethics committees of the participating institutions approved this registry (Approved number: M2020-102).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data supporting the findings of this study are available from the corresponding author upon reasonable request.BGCballoon-guiding catheterCIconfidence intervalCTcomputed tomographyDWIdiffusion-weighted imagingEVTendovascular treatmentEVDexternal ventricular drainageHILhyperintense lesionIPRintraprocedural ruptureIQRinterquartile rangeMRImagnetic resonance imagingmRSmodified Rankin ScaleORodds ratioPAOparent artery occlusionSAHsubarachnoid hemorrhageSTROBEStrengthening the Reporting of Observational Studies in EpidemiologyWFNSWorld Federation of Neurological Surgeons